Skip to content

Interactions of clozapine with the stimulus effects of DOM and LSD.

P A Palumbo, Jerrold C Winter

Pharmacology, Biochemistry, and Behavior September 1994 DOI: 10.1016/0091-3057(94)90464-2 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal drug discrimination study Peer reviewed
Population Rats trained in a two-lever drug discrimination task
Interventions 2 5-dimethoxy-4-methylamphetamine (DOM) lysergic acid diethylamide (LSD) clozapine atropine
Dose 0.3, 1, 2, and 3 mg/kg clozapine; 3 and 4 mg/kg clozapine; 3 and 5 mg/kg atropine; 2 mg/kg clozapine combined with 3 mg/kg atropine
Topics LSD
Key points Clozapine partially antagonized the discriminative stimulus effects of DOM (0.3, 1, 2 mg/kg) and LSD (3, 4 mg/kg), with full antagonism of DOM at 3 mg/kg, while neither drug fully generalized to clozapine. Atropine at 3 mg/kg partially generalized to and partially attenuated the DOM cue, and the authors conclude an antimuscarinic component in clozapine's attenuation cannot be excluded.

Abstract

Two groups of rats were trained with the 5-HT2 agonists 2,5-dimethoxy-4-methylamphetamine (DOM) or lysergic acid diethylamide (LSD) in a two-lever discrimination task. Tests of generalization and antagonism were then carried out with clozapine. DOM did not generalize to clozapine. Partial antagonism of DOM was observed with 0.3, 1, and 2 mg/kg clozapine and statistically significant full antagonism with 3 mg/kg. LSD did not fully generalize to clozapine. Partial antagonism of LSD was observed with 3 and 4 mg/kg clozapine. Because clozapine is known to block muscarinic as well as 5-HT2 receptors, atropine was studied in DOM-trained rats. DOM partially generalized to 3 mg/kg atropine. Partial attenuation of DOM stimulus effects was observed with 3 mg/kg atropine, and no attenuation with 5 mg/kg. A combination of 2 mg/kg clozapine and 3 mg/kg atropine vs. DOM produced response suppression in five of seven rats. The atropine test results do not exclude the possibility of an antimuscarinic component in the observed attenuation of DOM and LSD stimulus effects by clozapine.

Comparable studies

Other preclinical and animal studies on LSD, most cited first.

Study Year Design Participants
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex Human embryonic kidney 293 cells stably expressing 5-HT2ARs; wild-type and 5-HT2AR... 2003 Experimental study
Evidence for a central 5‐hydroxytryptamine receptor stimulation by lysergic acid diethylamide Rats 1968 Experimental study
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression Rats 2020 Preclinical study
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Male mice 2021 Multidisciplinary experimental study with in vivo electrophysiology, optogenetics, behavioral paradigms, molecular biology, and conditional knockout mice
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Mice and cultured rat cortical neurons 2023 Preclinical study

Citations in the library

Explore topics